Literature DB >> 6331932

Studies of the thymus in mice bearing the Lewis lung carcinoma. III. Possible mechanisms of tumor-induced thymic atrophy.

D Kaiserlian, W Savino, J Hassid, M Dardenne.   

Abstract

Adrenalectomy prevents thymic atrophy but not splenomegaly in mice implanted with Lewis Lung carcinoma cells. Surprisingly, the presence of the tumor does not lead to increased levels of corticosterone, which argues against an exclusive role of stress in the tumor-induced involution of the thymus. Interestingly, serum from tumor-bearing hosts in vitro displays strong cytolytic activity against normal syngeneic thymocytes. This thymocytotoxicity depends upon the stage of tumor development, i.e., the size of the local tumor, and is concomitant with the severe thymic atrophy. Treatment of donor mice with zinc chloride or excision of the local tumor, both of which have been shown to prevent this involution of the thymus, also abolishes the cytotoxic effect of the serum. The active component of the serum is a nonimmunoglobulin fraction of molecular weight greater than 25,000 Da. The possible mechanisms of tumor-dependent thymic atrophy as well as the in vivo relevance of this serum-mediated thymocytotoxicity are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6331932     DOI: 10.1016/0090-1229(84)90275-7

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  7 in total

Review 1.  Influence of breast cancer on thymic function in mice.

Authors:  Diana M Lopez; Vijaya Charyulu; Becky Adkins
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

Review 2.  Insights into thymic involution in tumor-bearing mice.

Authors:  Roberto Carrio; Diana M Lopez
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

3.  Comparative analysis of thymic subpopulations during different modes of atrophy identifies the reactive oxygen species scavenger, N-acetyl cysteine, to increase the survival of thymocytes during infection-induced and lipopolysaccharide-induced thymic atrophy.

Authors:  Shamik Majumdar; Vasista Adiga; Abinaya Raghavan; Supriya Rajendra Rananaware; Dipankar Nandi
Journal:  Immunology       Date:  2019-02-11       Impact factor: 7.397

4.  Establishment of a mouse model of cancer cachexia with spleen deficiency syndrome and the effects of atractylenolide I.

Authors:  Wan-Li Zhang; Na Li; Qiang Shen; Men Fan; Xiao-Dong Guo; Xiong-Wen Zhang; Zhou Zhang; Xuan Liu
Journal:  Acta Pharmacol Sin       Date:  2019-07-24       Impact factor: 6.150

5.  The Attenuated Live Yellow Fever Virus 17D Infects the Thymus and Induces Thymic Transcriptional Modifications of Immunomodulatory Genes in C57BL/6 and BALB/C Mice.

Authors:  Breno Luiz Melo-Lima; Danillo Lucas Alves Espósito; Benedito Antônio Lopes da Fonseca; Luiz Tadeu Moraes Figueiredo; Philippe Moreau; Eduardo Antonio Donadi
Journal:  Autoimmune Dis       Date:  2015-09-17

6.  A novel mechanism of tumor-induced thymic atrophy in mice bearing H22 hepatocellular carcinoma.

Authors:  Sujun Sun; Haiyu Ji; Yingying Feng; Yu Kang; Juan Yu; Anjun Liu
Journal:  Cancer Manag Res       Date:  2018-03-05       Impact factor: 3.989

Review 7.  Specific Targeting of Notch Ligand-Receptor Interactions to Modulate Immune Responses: A Review of Clinical and Preclinical Findings.

Authors:  Mounika U L Goruganthu; Anil Shanker; Mikhail M Dikov; David P Carbone
Journal:  Front Immunol       Date:  2020-08-14       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.